Novel role for the Streptococcus pneumoniae toxin pneumolysin in the assembly of biofilms

mBio

Volumn 4, Issue 5, 2013, Pages

  Shak, Joshua R ^a   Ludewick, Herbert P ^a,b   Howery, Kristen E ^a   Sakai, Fuminori ^a   Yi, Hong ^c   Harvey, Richard M ^d   Paton, James C ^d   Klugman, Keith P ^a   Vidal, Jorge E ^a  

^a EMORY UNIVERSITY   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

^c EMORY UNIVERSITY   (United States)

^d UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PNEUMOLYSIN; POLYSTYRENE;

ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BIOFILM; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EPITHELIUM CELL; EXTRACELLULAR MATRIX; GENE; GENE EXPRESSION; GENETIC VARIABILITY; HEMOLYSIS; HUMAN; HUMAN CELL; IMMUNOGOLD STAINING; INOCULATION; KNOCKOUT GENE; LUXS GENE; NONHUMAN; PLY GENE; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; STREPTOCOCCUS PNEUMONIAE; TOXIN ANALYSIS; TRANSMISSION ELECTRON MICROSCOPY; WILD TYPE;

BACTERIAL PROTEINS; BIOFILMS; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, BACTERIAL; HEMOLYSIN PROTEINS; HUMANS; LUNG; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE; STREPTOLYSINS;

EID: 84887137603     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00655-13     Document Type: Article

References (48)

1. O'Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N, Lee E, Mulholland K, Levine OS, Cherian T, Hib and Pneumococcal Global Burden of Disease Study Team. 2009. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 374:893-902.
2. Shak JR, Vidal JE, Klugman KP. 2013. Influence of bacterial interactions on pneumococcal colonization of the nasopharynx. Trends Microbiol. 21:129-135.
3. Domenech M, García E, Moscoso M. 2012. Biofilm formation in Streptococcus pneumoniae. Microb. Biotechnol. 5:455-465.
4. Hall-Stoodley L, Hu FZ, Gieseke A, Nistico L, Nguyen D, Hayes J, Forbes M, Greenberg DP, Dice B, Burrows A, Wackym PA, Stoodley P, Post JC, Ehrlich GD, Kerschner JE. 2006. Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. JAMA 296:202-211.
5. Reid SD, Hong W, Dew KE, Winn DR, Pang B, Watt J, Glover DT, Hollingshead SK, Swords WE. 2009. Streptococcus pneumoniae forms surface-attached communities in the middle ear of experimentally infected chinchillas. J. Infect. Dis. 199:786-794.
6. Weimer KE, Armbruster CE, Juneau RA, Hong W, Pang B, Swords WE. 2010. Coinfection with Haemophilus influenzae promotes pneumococcal biofilm formation during experimental otitis media and impedes the progression of pneumococcal disease. J. Infect. Dis. 202:1068-1075.
7. Vidal JE, Ludewick HP, Kunkel RM, Zähner D, Klugman KP. 2011. The LuxS-dependent quorum-sensing system regulates early biofilm formation by Streptococcus pneumoniae strain D39. Infect. Immun. 79: 4050-4060.
8. Trappetti C, Potter AJ, Paton AW, Oggioni MR, Paton JC. 2011. LuxS mediates iron-dependent biofilm formation, competence, and fratricide in Streptococcus pneumoniae. Infect. Immun. 79:4550-4558.
9. Paton JC, Andrew PW, Boulnois GJ, Mitchell TJ. 1993. Molecular analysis of the pathogenicity of Streptococcus pneumoniae: the role of pneumococcal proteins. Annu. Rev. Microbiol. 47:89-115.
10. Hirst RA, Gosai B, Rutman A, Guerin CJ, Nicotera P, Andrew PW, O'Callaghan C. 2008. Streptococcus pneumoniae deficient in pneumolysin or autolysin has reduced virulence in meningitis. J. Infect. Dis. 197: 744-751.
11. Price KE, Camilli A. 2009. Pneumolysin localizes to the cell wall of Streptococcus pneumoniae. J. Bacteriol. 191:2163-2168.
12. Alouf JE. 2000. Cholesterol-binding cytolytic protein toxins. Int. J. Med. Microbiol. 290:351-356.
13. Berry AM, Alexander JE, Mitchell TJ, Andrew PW, Hansman D, Paton JC. 1995. Effect of defined point mutations in the pneumolysin gene on the virulence of Streptococcus pneumoniae. Infect. Immun. 63:1969-1974.
14. Kaur R, Casey JR, Pichichero ME. 2011. Serum antibody response to five Streptococcus pneumoniae proteins during acute otitis media in otitisprone and non-otitis-prone children. Pediatr. Infect. Dis. J. 30:645-650.
15. Simell B, Korkeila M, Pursiainen H, Kilpi TM, Käyhty H. 2001. Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal surface adhesin a, pneumolysin, and pneumococcal surface protein a in children. J. Infect. Dis. 183:887-896.
16. Rapola S, Kilpi T, Lahdenkari M, Mäkelä PH, Käyhty H. 2001. Antibody response to the pneumococcal proteins pneumococcal surface adhesin A and pneumolysin in children with acute otitis media. Pediatr. Infect. Dis. J. 20:482-487.
17. Malley R, Henneke P, Morse SC, Cieslewicz MJ, Lipsitch M, Thompson CM, Kurt-Jones E, Paton JC, Wessels MR, Golenbock DT. 2003. Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc. Natl. Acad. Sci. U. S. A. 100:1966-1971.
18. Dogan S, Zhang Q, Pridmore AC, Mitchell TJ, Finn A, Murdoch C. 2011. Pneumolysin-induced CXCL8 production by nasopharyngeal epithelial cells is dependent on calcium flux and MAPK activation via Tolllike receptor 4. Microbes Infect. 13:65-75.
19. Malley R, Anderson PW. 2012. Serotype-independent pneumococcal experimental vaccines that induce cellular as well as humoral immunity. Proc. Natl. Acad. Sci. U. S. A. 109:3623-3627.
20. Salha D, Szeto J, Myers L, Claus C, Sheung A, Tang M, Ljutic B, Hanwell D, Ogilvie K, Ming M, Messham B, van den Dobbelsteen G, Hopfer R, Ochs MM, Gallichan S. 2012. Neutralizing antibodies elicited by a novel detoxified pneumolysin derivative, PlyD1, provide protection against both pneumococcal infection and lung injury. Infect. Immun. 80: 2212.
21. Kamtchoua T, Bologa M, Hopfer R, Neveu D, Hu B, Sheng X, Corde N, Pouzet C, Zimmermann G, Gurunathan S. 2013. Safety and immunogenicity of the pneumococcal pneumolysin derivative PlyD1 in a singleantigen protein vaccine candidate in adults. Vaccine 31:327-333.
22. Caiazza NC, O'Toole GA. 2003. Alpha-toxin is required for biofilm formation by Staphylococcus aureus. J. Bacteriol. 185:3214-3217.
23. Anderson MJ, Lin YC, Gillman AN, Parks PJ, Schlievert PM, Peterson ML. 2012. Alpha-toxin promotes Staphylococcus aureus mucosal biofilm formation. Front. Cell. Infect. Microbiol. 2:64.
24. Allegrucci M, Hu FZ, Shen K, Hayes J, Ehrlich GD, Post JC, Sauer K. 2006. Phenotypic characterization of Streptococcus pneumoniae biofilm development. J. Bacteriol. 188:2325-2335.
25. Marks LR, Parameswaran GI, Hakansson AP. 2012. Pneumococcal interactions with epithelial cells are crucial for optimal biofilm formation and colonization in vitro and in vivo. Infect. Immun. 80:2744-2760.
26. Joyce EA, Kawale A, Censini S, Kim CC, Covacci A, Falkow S. 2004. LuxS is required for persistent pneumococcal carriage and expression of virulence and biosynthesis genes. Infect. Immun. 72:2964-2975.
27. Vidal JE, Howery KE, Ludewick HP, Nava P, Klugman KP. 2013. Quorum-sensing systems LuxS/autoinducer 2 and com regulate Streptococcus pneumoniae biofilms in a bioreactor with living cultures of human respiratory cells. Infect. Immun. 81:1341-1353.
28. Kirkham LA, Jefferies JM, Kerr AR, Jing Y, Clarke SC, Smith A, Mitchell TJ. 2006. Identification of invasive serotype 1 pneumococcal isolates that express nonhemolytic pneumolysin. J. Clin. Microbiol. 44: 151-159.
29. Harvey RM, Ogunniyi AD, Chen AY, Paton JC. 2011. Pneumolysin with low hemolytic activity confers an early growth advantage to Streptococcus pneumoniae in the blood. Infect. Immun. 79:4122-4130.
30. Oggioni MR, Trappetti C, Kadioglu A, Cassone M, Iannelli F, Ricci S, Andrew PW, Pozzi G. 2006. Switch from planktonic to sessile life: a major event in pneumococcal pathogenesis. Mol. Microbiol. 61:1196-1210.
31. Lizcano A, Chin T, Sauer K, Tuomanen EI, Orihuela CJ. 2010. Early biofilm formation on microtiter plates is not correlated with the invasive disease potential of Streptococcus pneumoniae. Microb. Pathog. 48: 124-130.
32. Wei H, Håvarstein LS. 2012. Fratricide is essential for efficient gene transfer between pneumococci in biofilms. Appl. Environ. Microbiol. 78: 5897-5905.
33. Moscoso M, García E, López R. 2006. Biofilm formation by Streptococcus pneumoniae: role of choline, extracellular DNA, and capsular polysaccharide in microbial accretion. J. Bacteriol. 188:7785-7795.
34. Qin L, Kida Y, Imamura Y, Kuwano K, Watanabe H. 2013. Impaired capsular polysaccharide is relevant to enhanced biofilm formation and lower virulence in Streptococcus pneumoniae. J. Infect. Chemother. 19: 261-271.
35. Hall-Stoodley L, Nistico L, Sambanthamoorthy K, Dice B, Nguyen D, Mershon WJ, Johnson C, Hu FZ, Stoodley P, Ehrlich GD, Post JC. 2008. Characterization of biofilm matrix, degradation by DNase treatment and evidence of capsule downregulation in Streptococcus pneumoniae clinical isolates. BMC Microbiol. 8:173.
36. Berry AM, Yother J, Briles DE, Hansman D, Paton JC. 1989. Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae. Infect. Immun. 57:2037-2042.
37. Marriott HM, Mitchell TJ, Dockrell DH. 2008. Pneumolysin: a doubleedged sword during the host-pathogen interaction. Curr. Mol. Med. 8:497-509.
38. Ljutic B, Ochs M, Messham B, Ming M, Dookie A, Harper K, Ausar SF. 2012. Formulation, stability and immunogenicity of a trivalent pneumococcal protein vaccine formulated with aluminum salt adjuvants. Vaccine 30:2981-2988.
39. Mahdi LK, Wang H, Van der Hoek MB, Paton JC, Ogunniyi AD. 2012. Identification of a novel pneumococcal vaccine antigen preferentially expressed during meningitis in mice. J. Clin. Invest. 122:2208-2220.
40. Simell B, Auranen K, Käyhty H, Goldblatt D, Dagan R, O'Brien KL, Pneumococcal Carriage Group. 2012. The fundamental link between pneumococcal carriage and disease. Expert Rev. Vaccines 11:841-855.
41. Wright CS. 1984. Structural comparison of the two distinct sugar binding sites in wheat germ agglutinin isolectin II. J. Mol. Biol. 178:91-104.
42. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
43. Fisher DJ, Miyamoto K, Harrison B, Akimoto S, Sarker MR, McClane BA. 2005. Association of beta2 toxin production with Clostridium perfringens type A human gastrointestinal disease isolates carrying a plasmid enterotoxin gene. Mol. Microbiol. 56:747-762.
44. Lau PC, Sung CK, Lee JH, Morrison DA, Cvitkovitch DG. 2002. PCR ligation mutagenesis in transformable streptococci: application and efficiency. J. Microbiol. Methods 49:193-205.
45. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(CT) method. Methods 25:402-408.
46. Avery OT, Macleod CM, McCarty M. 1944. Studies on the chemical nature of the substance inducing transformation of pneumococcal types: induction of transformation by a desoxyribonucleic acid fraction isolated from pneumococcus type III. J. Exp. Med. 79:137-158.
47. Price KE, Greene NG, Camilli A. 2012. Export requirements of pneumolysin in Streptococcus pneumoniae. J. Bacteriol. 194:3651-3660.
48. Nieto C, Espinosa M. 2003. Construction of the mobilizable plasmid pMV158GFP, a derivative of pMV158 that carries the gene encoding the green fluorescent protein. Plasmid 49:281-285.